Riskpilot← Back to searchSign inGet full accessAfecto Medical AB
ABActiveOrg 5568920960Solberga Hagväg 1General medical practice activities · NACE 8621Est. 2012100-199 employees
Revenue 2024
SEK 92,2M
+32% vs 2023
EBITDA margin
3.4%
-52% vs 2023
Equity ratio
9.3%
Financial strength
Net profit 2024
SEK 809K
-78% vs 2023
| Revenue | SEK 92,2M | +32% |
| EBITDA | SEK 3,1M | -52% |
| Net profit | SEK 809K | -78% |
| Total assets | SEK 18,3M | +2% |
| Equity | SEK 1,7M | -56% |
| Employees | — | — |
Legal name
Afecto Medical AB
Org number
5568920960
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 maj 2012
Share capital
SEK 50 000
Employees
100-199
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Läkarkonsultation. Sjukvård. Konsultation inom sjukvård. Under- visning. Forskning. Läkemedelsutveckling. Handel med fast och lös egendom (instrument, maskiner, läkemedel, vårdmaterial). Investering och kapitalplacering. Sjukvårdsutveckling. Bemanning.
Address
Solberga Hagväg 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 36 883 | 42 342 | 45 588 | 70 068 | 92 157 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 7 552 | 6 188 | 2 752 | 6 499 | 3 104 |
| Depreciation & amort. | −1 210 | −932 | −632 | −577 | −958 |
| EBIT | 6 342 | 5 256 | 2 120 | 5 922 | 2 146 |
| Net financials | −1 | −4 | −5 | 23 | 92 |
| Profit before tax | 4 741 | 3 952 | 1 615 | 4 644 | 1 138 |
| Tax | −1 056 | −840 | −394 | −994 | −329 |
| Net profit | 3 685 | 3 112 | 1 221 | 3 650 | 809 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 660 | 17 331 | 13 735 | 18 019 | 18 334 |
| Equity | 5 009 | 8 121 | 1 342 | 3 892 | 1 701 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 752 | 5 010 | 7 693 | 8 127 | 11 933 |
| Total debt | 4 752 | 5 010 | 7 693 | 8 127 | 11 933 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
9.3%
This company
38.2%
Market median
-76% vs market
20202024
Return on equity
47.6%
This company
18.4%
Market median
+159% vs market
20202024
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20202024
Asset turnover
5.03×
This company
1.12×
Market median
+349% vs market
20202024
Debt / equity
9.78×
This company
0.62×
Market median
-1477% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NT Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Afecto Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ninos Turgay | Audit | 0 companies |
| Inga Louise Lönndahl | Deputy Board Member | 0 companies |
| Hassan Killasli | Board of Directors | 0 companies |